Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Storage
-15°C to -25°C/1 year(Do not lower than -25°C)
Concentration
1 mg/ml
Clonality
Polyclonal
Clone Number
Immunogen
Synthesized peptide derived from human CBR4
Specificity
This antibody detects endogenous levels of CBR4 at Human, Mouse,Rat
Gene Name
CBR4
Protein Name
Carbonyl reductase family member 4 (3-oxoacyl-[acyl-carrier-protein] reductase) (Quinone reductase CBR4)
Other Name
Species
Human
Gene ID
84869
Uniprot
Q8N4T8,
Species.1
Mouse
Gene ID.1
234309
Uniprot.1
Q91VT4,
Species.2
Rat
Gene ID.2
359725
Uniprot.2
Q7TS56
Cellular Localization
Mitochondrion matrix .
Tissue Expression
Detected in liver and kidney (at protein level) (PubMed:19000905). Displays the highest expression in neuronal and muscle tissues (PubMed:25203508).
Signaling_pathway
Research Areas
Function
Component of the heterotetramer complex KAR (3-ketoacyl-[acyl carrier protein] reductase or 3-ketoacyl-[ACP] reductase) that forms part of the mitochondrial fatty acid synthase (mtFAS). Beta-subunit of the KAR heterotetramer complex, responsible for the 3-ketoacyl-ACP reductase activity of the mtFAS, reduces 3-oxoacyl-[ACP] to (3R)-hydroxyacyl-[ACP] in a NADPH-dependent manner with no chain length preference, thereby participating in mitochondrial fatty acid biosynthesis . The homotetramer has NADPH-dependent quinone reductase activity (in vitro), hence could play a role in protection against cytotoxicity of exogenous quinones . As a heterotetramer, it can also reduce 9,10-phenanthrenequinone, 1,4-benzoquinone and various other o-quinones and p-quinones (in vitro) .